Atomoksetin (Norwegian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Atomoksetin" in Norwegian language version.

refsWebsite

Global rank Norwegian rank

9nih.gov

4^th place

23^rd place

7worldcat.org

5^th place

13^th place

5doi.org

2^nd place

9^th place

3web.archive.org

1^st place

2drugs.com

399^th place

2,066^th place

2legemiddelverket.no

low place

1,694^th place

1medscape.com

719^th place

2,150^th place

1tga.gov.au

3,984^th place

low place

1psychiatry.org

low place

1fhi.no

low place

211^th place

doi.org

Treuer, Tamás; Gau, Susan Shur-Fen; Méndez, Luis; Montgomery, William; Monk, Julie A.; Altin, Murat; Wu, Shenghu; Lin, Chaucer C.H.; Dueñas, Héctor J. (23. april 2013). «A Systematic Review of Combination Therapy with Stimulants and Atomoxetine for Attention-Deficit/Hyperactivity Disorder, Including Patient Characteristics, Treatment Strategies, Effectiveness, and Tolerability». Journal of Child and Adolescent Psychopharmacology. 3. 23: 179–193. ISSN 1044-5463. PMC 3696926 . PMID 23560600. doi:10.1089/cap.2012.0093. Besøkt 9. juli 2022.
Chan, Eugenia; Fogler, Jason M.; Hammerness, Paul G. (10. mai 2016). «Treatment of Attention-Deficit/Hyperactivity Disorder in Adolescents: A Systematic Review». JAMA. 18. 315: 1997–2008. ISSN 1538-3598. PMID 27163988. doi:10.1001/jama.2016.5453. Besøkt 9. juli 2022.
Sofuoglu, Mehmet; DeVito, Elise E.; Waters, Andrew J.; Carroll, Kathleen M. (januar 2013). «Cognitive Enhancement as a Treatment for Drug Addictions». Neuropharmacology. 1. 64: 452–463. ISSN 0028-3908. PMC 3445733 . PMID 22735770. doi:10.1016/j.neuropharm.2012.06.021. Besøkt 9. juli 2022.
Ornoy, Asher (6. februar 2018). «Pharmacological Treatment of Attention Deficit Hyperactivity Disorder During Pregnancy and Lactation». Pharmaceutical Research. 3. 35: 46. ISSN 1573-904X. PMID 29411149. doi:10.1007/s11095-017-2323-z. Besøkt 9. juli 2022.
Sauer, John-Michael; Ring, Barbara J.; Witcher, Jennifer W. (2005). «Clinical pharmacokinetics of atomoxetine». Clinical Pharmacokinetics. 6. 44: 571–590. ISSN 0312-5963. PMID 15910008. doi:10.2165/00003088-200544060-00002. Besøkt 9. juli 2022.

drugs.com

«Atomoxetine Monograph for Professionals». Drugs.com (på engelsk). American Society of Health-System Pharmacists. Arkivert fra originalen 4. april 2019. Besøkt 22. mars 2019.
«Atomoxetine (Strattera) Use During Pregnancy». Drugs.com (på engelsk). Arkivert fra originalen 22. mars 2019. Besøkt 3. mars 2019.

fhi.no

Nasjonalt folkehelseinstitutt: Legemidler ved ADHD Arkivert 8. januar 2013 hos Wayback Machine.. Oppdatert 15. januar 2008

legemiddelverket.no

Statens legemiddelverk / Kristin Helene Svanqvist (20. oktober 2008). Refusjonsrapport – Strattera (atomoksetin) til behandling av ADHD^{[død lenke]}, s. 10 (4.2 Klinisk effekt av atomoksetin)
«Strattera på blå resept fra 1. november». Legemiddelverket. 18. oktober 2008. Besøkt 30. oktober 2012. ^{[død lenke]}

medscape.com

reference.medscape.com

«atomoxetine (Rx) - Strattera». Medscape Reference. WebMD. Besøkt 10. november 2013.

nih.gov

ncbi.nlm.nih.gov

Treuer, Tamás; Gau, Susan Shur-Fen; Méndez, Luis; Montgomery, William; Monk, Julie A.; Altin, Murat; Wu, Shenghu; Lin, Chaucer C.H.; Dueñas, Héctor J. (23. april 2013). «A Systematic Review of Combination Therapy with Stimulants and Atomoxetine for Attention-Deficit/Hyperactivity Disorder, Including Patient Characteristics, Treatment Strategies, Effectiveness, and Tolerability». Journal of Child and Adolescent Psychopharmacology. 3. 23: 179–193. ISSN 1044-5463. PMC 3696926 . PMID 23560600. doi:10.1089/cap.2012.0093. Besøkt 9. juli 2022.
Chan, Eugenia; Fogler, Jason M.; Hammerness, Paul G. (10. mai 2016). «Treatment of Attention-Deficit/Hyperactivity Disorder in Adolescents: A Systematic Review». JAMA. 18. 315: 1997–2008. ISSN 1538-3598. PMID 27163988. doi:10.1001/jama.2016.5453. Besøkt 9. juli 2022.
Sofuoglu, Mehmet; DeVito, Elise E.; Waters, Andrew J.; Carroll, Kathleen M. (januar 2013). «Cognitive Enhancement as a Treatment for Drug Addictions». Neuropharmacology. 1. 64: 452–463. ISSN 0028-3908. PMC 3445733 . PMID 22735770. doi:10.1016/j.neuropharm.2012.06.021. Besøkt 9. juli 2022.
Ornoy, Asher (6. februar 2018). «Pharmacological Treatment of Attention Deficit Hyperactivity Disorder During Pregnancy and Lactation». Pharmaceutical Research. 3. 35: 46. ISSN 1573-904X. PMID 29411149. doi:10.1007/s11095-017-2323-z. Besøkt 9. juli 2022.
Sauer, John-Michael; Ring, Barbara J.; Witcher, Jennifer W. (2005). «Clinical pharmacokinetics of atomoxetine». Clinical Pharmacokinetics. 6. 44: 571–590. ISSN 0312-5963. PMID 15910008. doi:10.2165/00003088-200544060-00002. Besøkt 9. juli 2022.

pubmed.ncbi.nlm.nih.gov

Chan, Eugenia; Fogler, Jason M.; Hammerness, Paul G. (10. mai 2016). «Treatment of Attention-Deficit/Hyperactivity Disorder in Adolescents: A Systematic Review». JAMA. 18. 315: 1997–2008. ISSN 1538-3598. PMID 27163988. doi:10.1001/jama.2016.5453. Besøkt 9. juli 2022.
Ornoy, Asher (6. februar 2018). «Pharmacological Treatment of Attention Deficit Hyperactivity Disorder During Pregnancy and Lactation». Pharmaceutical Research. 3. 35: 46. ISSN 1573-904X. PMID 29411149. doi:10.1007/s11095-017-2323-z. Besøkt 9. juli 2022.
Sauer, John-Michael; Ring, Barbara J.; Witcher, Jennifer W. (2005). «Clinical pharmacokinetics of atomoxetine». Clinical Pharmacokinetics. 6. 44: 571–590. ISSN 0312-5963. PMID 15910008. doi:10.2165/00003088-200544060-00002. Besøkt 9. juli 2022.

dailymed.nlm.nih.gov

«ATOMOXETINE HYDROCHLORIDE capsule [Mylan Pharmaceuticals Inc.]». DailyMed. Mylan Pharmaceuticals Inc. oktober 2011. Besøkt 10. november 2013.

psychiatry.org

«Parent's Medication Guide: ADHD». American Psychiatric Association (på engelsk). American Psychiatric Association & American Academy of Child and Adolescent Psychiatry (AACAP). juni 2013. Besøkt 9. juli 2022. «Though not FDA-approved for combined treatment, atomoxetine (Strattera) is sometimes used in conjunction with stimulants as an off-label combination therapy.»

tga.gov.au

ebs.tga.gov.au

«STRATTERA® (atomoxetine hydrochloride)». TGA eBusiness Services. Eli Lilly Australia Pty. Limited. 21. august 2013. Besøkt 10. november 2013.

web.archive.org

«Atomoxetine Monograph for Professionals». Drugs.com (på engelsk). American Society of Health-System Pharmacists. Arkivert fra originalen 4. april 2019. Besøkt 22. mars 2019.
Nasjonalt folkehelseinstitutt: Legemidler ved ADHD Arkivert 8. januar 2013 hos Wayback Machine.. Oppdatert 15. januar 2008
«Atomoxetine (Strattera) Use During Pregnancy». Drugs.com (på engelsk). Arkivert fra originalen 22. mars 2019. Besøkt 3. mars 2019.

worldcat.org

Treuer, Tamás; Gau, Susan Shur-Fen; Méndez, Luis; Montgomery, William; Monk, Julie A.; Altin, Murat; Wu, Shenghu; Lin, Chaucer C.H.; Dueñas, Héctor J. (23. april 2013). «A Systematic Review of Combination Therapy with Stimulants and Atomoxetine for Attention-Deficit/Hyperactivity Disorder, Including Patient Characteristics, Treatment Strategies, Effectiveness, and Tolerability». Journal of Child and Adolescent Psychopharmacology. 3. 23: 179–193. ISSN 1044-5463. PMC 3696926 . PMID 23560600. doi:10.1089/cap.2012.0093. Besøkt 9. juli 2022.
Nestler, Eric J. (2015). Molecular neuropharmacology : a foundation for clinical neuroscience (Third edition utg.). New York: McGraw-Hill. ISBN 978-0-07-182770-6. OCLC 903249658. CS1-vedlikehold: Ekstra tekst (link)
Chan, Eugenia; Fogler, Jason M.; Hammerness, Paul G. (10. mai 2016). «Treatment of Attention-Deficit/Hyperactivity Disorder in Adolescents: A Systematic Review». JAMA. 18. 315: 1997–2008. ISSN 1538-3598. PMID 27163988. doi:10.1001/jama.2016.5453. Besøkt 9. juli 2022.
Sofuoglu, Mehmet; DeVito, Elise E.; Waters, Andrew J.; Carroll, Kathleen M. (januar 2013). «Cognitive Enhancement as a Treatment for Drug Addictions». Neuropharmacology. 1. 64: 452–463. ISSN 0028-3908. PMC 3445733 . PMID 22735770. doi:10.1016/j.neuropharm.2012.06.021. Besøkt 9. juli 2022.
BNF 76 : September 2018. London. 2018. ISBN 978-0-85711-338-2. OCLC 1064479788.
Ornoy, Asher (6. februar 2018). «Pharmacological Treatment of Attention Deficit Hyperactivity Disorder During Pregnancy and Lactation». Pharmaceutical Research. 3. 35: 46. ISSN 1573-904X. PMID 29411149. doi:10.1007/s11095-017-2323-z. Besøkt 9. juli 2022.
Sauer, John-Michael; Ring, Barbara J.; Witcher, Jennifer W. (2005). «Clinical pharmacokinetics of atomoxetine». Clinical Pharmacokinetics. 6. 44: 571–590. ISSN 0312-5963. PMID 15910008. doi:10.2165/00003088-200544060-00002. Besøkt 9. juli 2022.